Caplin Point Laboratories Ltd Half Yearly Results

Gross Sales

1,044.26

995.41

942.06

888.72

805.38

Excise Duty

0

0

0

0

0

Net Sales

1,044.26

995.41

942.06

888.72

805.38

Other Operating Income

0

0

0

0

0

Other Income

53.56

57.1

39.33

34.55

32.66

Total Income

1,097.82

1,052.51

981.39

923.27

838.04

Total Expenditure

677.33

664.98

625.57

601.21

541.45

PBIDT

420.49

387.53

355.82

322.06

296.59

Interest

0.34

0.35

0.26

0.32

0.46

PBDT

420.15

387.18

355.56

321.74

296.13

Depreciation

34.69

33.24

32.72

30.3

23.14

Minority Interest Before NP

0

0

0

0

0

Tax

69.63

63.49

61.84

46.58

54.97

Deferred Tax

4.84

5.09

5.27

3.81

-2.35

Reported Profit After Tax

310.99

285.36

255.73

241.05

220.37

Minority Interest After NP

3.74

3.82

0.96

2.26

2.07

Net Profit after Minority Interest

307.25

281.54

254.77

238.79

218.3

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

307.25

281.54

254.77

238.79

218.3

EPS (Unit Curr.)

40.42

37.04

33.54

31.44

28.75

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

100

Equity

15.02

15.2

15.2

15.19

15.19

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

40.26

38.93

37.77

36.23

36.82

PBDTM(%)

-

-

-

-

-

PATM(%)

29.78

28.66

27.14

27.12

27.36